<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Adipophilin as prognostic biomarker in clear cell renal cell carcinoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-02-23">February 23, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Yuri</forename><surname>Tolkach</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Pathology</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Lüders</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Pathology</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Meller</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute for Pathology</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Klaus</forename><surname>Jung</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute of Urologic Research</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Stephan</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Berlin Institute of Urologic Research</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Glen</forename><surname>Kristiansen</surname></persName>
							<email>glen.kristiansen@ukb.uni-bonn.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute for Pathology</orgName>
								<orgName type="institution">University Hospital Bonn</orgName>
								<address>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Adipophilin as prognostic biomarker in clear cell renal cell carcinoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-02-23">February 23, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">FF1204FF5E351C7065DD2132BE6E3E1E</idno>
					<note type="submission">Received: December 12, 2016 Accepted: January 27, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>renal cell carcinoma</term>
					<term>clear cell</term>
					<term>adipophilin</term>
					<term>perilipin 2</term>
					<term>PLIN2</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objective: To study the expression of adipophilin (PLIN2), a lipid storageassociated cell protein, in different subtypes of renal cell cancer and to elucidate its prognostic value.</s></p><p><s>Materials and Methods: Two-hundred-seventy-five patients with renal cell carcinoma (RCC) were included in this study.</s><s>Immunohistochemistry with a polyclonal antibody to adipophilin was used on the tissue microarray (formalin-fixed, paraffinembedded tissue) for detection of adipophilin.</s><s>Median follow-up time was 91 (range 1-159) months in the whole cohort and 100 (1-159) months for patients with clearcell RCC.</s><s>Additional validation for adipophilin was performed using publicly available gene expression data for clear cell RCC from The Cancer Genome Atlas (TCGA).</s></p><p><s>Results: Adipophilin expression was detected in 14.3% of papillary RCC, in 0% of chromophobe RCC and in 58.7% of clear-cell RCC in the cytoplasm or at the membrane.</s><s>Only membrane expression was correlated with other clinical parameters (pT-stage, pN-stage, R-status, sex) and showed a prognostic significance in univariate analysis with regard to overall survival of patients with clear cell subtype (HR 2.90, 95% CI 1.55-5.42,</s><s>p=0.001), which failed significance on multivariate analysis.</s><s>mRNA expression of PLIN2 on TCGA data using best selected cut-off was prognostically significant in both univariate (HR 1.76, 95% CI 1.28-2.42,</s><s>p = 0.0005) and multivariate analyses (HR 1.46, 95% CI 1.05-2.04,</s><s>p = 0.0257).</s></p><p><s>Conclusions: Adipophilin is a novel and still understudied prognostic biomarker in clear cell renal cell carcinoma which deserves further study.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Kidney cancer is one of the ten most frequently occurring cancers with substantial mortality estimates in Western societies <ref type="bibr" target="#b0">[1]</ref>.</s><s>Constant search for powerful biomarkers capable of prognostication and prediction of therapy response in this type of tumors is one of the priorities of modern medicine and science.</s></p><p><s>Importantly, all tumors are considered to undergo certain metabolic changes to achieve high proliferation rates and sustain further growth.</s><s>At that, lipid metabolism supposed to be seriously altered in many tumor types <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Adipophilin is one of the important players in lipid metabolism, responsible for storage of lipid droplets in all types of cells <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>Some recent studies show that many tumors overexpress adipophilin <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b19">[19]</ref><ref type="bibr" target="#b20">[20]</ref><ref type="bibr" target="#b21">[21]</ref><ref type="bibr" target="#b22">[22]</ref>, especially those with clear cell histology <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s>Several small reports showed that renal cell carcinoma (RCC) cells also overexpress adipophilin <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b23">[23]</ref><ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref><ref type="bibr" target="#b26">[26]</ref><ref type="bibr" target="#b27">[27]</ref> and one major study <ref type="bibr" target="#b24">[24]</ref> reported the prognostic role of this biomarker in clear cell subtype on transcript level.</s><s>However, an analysis on the protein level was pending, so far.</s></p><p><s>In this study we aimed to investigate the expression patterns of adipophilin using immunohistochemistry in patients with different subtypes of the renal cell cancer and to study the prognostic effect of this biomarker on the survival of patients Table <ref type="table" target="#tab_0">1</ref>.</s><s>For further validation we have used the publicly available expression data set of PLIN2 (adipophilin) from The Cancer Genome Atlas (TCGA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry: staining patterns</head><p><s>Adipophilin immunohistochemistry shows immunoreactivity of cytoplasm, membrane or both (Figure <ref type="figure" target="#fig_1">1</ref>).</s><s>Cytoplasm staining of RCC tumor cells showed vesicular (drop-like) or granular pattern.</s><s>Cell nuclei were negative in all cases.</s><s>There was no noteworthy heterogeneity of immunoreactivity at the level of individual cells.</s><s>The frequency and the expression levels are displayed in Table <ref type="table" target="#tab_1">2</ref>. Since immunoreactivity to adipophilin was almost exclusively detected in clear cell RCC (CC-RCC), we restricted the further analysis to these 230 patients (Supplementary Table <ref type="table" target="#tab_0">1</ref> for clinical characteristics).</s><s>Among these, 95 patients were completely negative, 135 patients were positive at one (membrane or cytoplasm) or both locations at any staining grade.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Associations between adipophilin expression and clinical parameters</head><p><s>Cytoplasm positivity for adipophilin demonstrated no significant associations with common prognostic parameters (staging, grading) and other important patient-related variables (sex, age).</s><s>Quite the contrary, membrane staining was more intensive in patients with less advanced and higher differentiated tumors.</s><s>Furthermore women compared to men presented with membrane positivity more often (Exact Fischer's test p&lt;0.00001; Figure <ref type="figure" target="#fig_2">2</ref>).</s><s>At that, all six cases of strong ("3") membrane immunoreactivity were female patients.</s><s>No associations were found for patient age.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Survival analyses</head><p><s>Kaplan Meier analysis with log-rank test (Figure <ref type="figure" target="#fig_3">3</ref>), as well as univariate analysis (Cox regression) (Table <ref type="table" target="#tab_2">3</ref>) demonstrated that only membrane staining of adipophilin was prognostically relevant for overall survival (in univariate analysis HR 2.90 for low vs high membrane expression for negative outcome, 95% CI 1.55-5.42,</s><s>p=0.001).</s><s>However, on multivariate analysis adipophilin expression at the membrane showed no independent prognostic value (Table <ref type="table" target="#tab_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of TCGA cohort</head><p><s>The mean expression of PLIN2 mRNA in tumor tissue was 22678 (range 279-159128), in normal renal parenchyma 2855 (range 911-25707) with significant difference (p&lt;0.0001).</s><s>The best cutoff according to the Cox-model-based selection was 17995, splitting the cohort into subgroups with low (n=239) and high (n=250) expression of PLIN2 mRNA (See Supplementary Table <ref type="table" target="#tab_3">4</ref>).</s><s>Log-rank analysis of the Kaplan-Meyer curves (Figure <ref type="figure" target="#fig_4">4</ref>) revealed significantly better overall survival in the subgroup with high expression (p=0.0004).</s><s>Univariate Cox analysis HR for this cut-off showed the HR of 1.76 (95% CI 1.28-2.42)</s><s>with p = 0.0005 (See Supplementary Table <ref type="table" target="#tab_1">2</ref>).</s><s>In multivariate Cox analysis with inclusion of pTstage, pN-stage and WHO/ISUP-Grade of the tumor into the model the HR for low expression vs high expression was 1.46 (95% CI 1.05-2.04)</s><s>with p = 0.0257 (see Supplementary Table <ref type="table" target="#tab_2">3</ref>).</s><s>When PLIN2 mRNA-expression was used as continuous parameter, the significance level was of the same order: in univariate Cox analysis HR was 0,986 (0,976-0.996)</s><s>for step-wise increase at every 1000 transcripts of mRNA (p=0,005), in multivariate analysis using the same set of the parameters as for cut-off-based version of model -HR 0,989 (0,979-0,999) for step-wise increase at every 1000 transcripts of mRNA (p=0,045).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Adipophilin (adipocyte differentiation-related protein, perilipin-2) is a member of the perilipin protein family, consisting of 3 members (also perilipin-1 and perilipin-3), which coat the lipid droplets in the cytoplasm of diverse cells and therefore allow the storage of energy-rich fats <ref type="bibr" target="#b3">[4]</ref>.</s><s>The functional correlations are almost mechanistic: accumulation of lipids in the cell will lead to increased expression of adipophilin.</s><s>This process could be indeed observed in its purity in adipocytes, where adipophilin was first described as a membrane-associated protein <ref type="bibr" target="#b4">[5]</ref>.</s><s>Although the function of adipophilin as lipid droplet wall component is relatively straightforward, many authors consider, that its functions extend far beyond the structural role.</s><s>It was shown, that modulation of adipophilin expression in hepatocytes in mice affected expression of 1363 genes with primary metabolic orientation <ref type="bibr" target="#b29">[29]</ref>.</s></p><p><s>Adipophilin is not a tumor-specific biomarker, as it was shown, that adipophilin expression is affected in a wide range of metabolic disorders in almost all tissue types <ref type="bibr" target="#b3">[4]</ref>.</s><s>Nevertheless, many tumor types are recognized for their lipid metabolism disturbances, which supposed to be partly related to the metabolic reprogramming of the tumor cells and issues, related to energy consumption in a hypoxic microenvironment <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Thus, adipophilin fell into the scope of cancer researchers and was already addressed in several tumor types as being overexpressed <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b19">[19]</ref><ref type="bibr" target="#b20">[20]</ref><ref type="bibr" target="#b21">[21]</ref><ref type="bibr" target="#b22">[22]</ref>.</s><s>Two studies showed that most tumors with clear-cell histology accumulate adipophilin <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s>Moreover, at the level of mRNA expression PLIN2 (gene coding adipophilin) appears to be an outlier for virtually all tumor entities as summarized using cancer outlier profile analysis in the Oncomine database (see Supplementary Discussion 1).</s><s>In our study only 5/35 cases of papillary RCC tumors were positive to adipophilin using immunohistochemistry.</s><s>All 10 chromophobe tumors were negative.</s><s>Positive staining at one of two locations (membrane or cytoplasm; nuclear staining was not observed) was detected in 58.7% (135/230) of patients with CC-RCC with higher expression in less aggressive tumors.</s><s>This is in trend of previous studies.</s></p><p><s>Two studies from one group <ref type="bibr" target="#b23">[23,</ref><ref type="bibr" target="#b24">24]</ref> revealed that high PLIN2 mRNA expression is associated with a favorable cancer-specific survival in CC-RCC patients.</s><s>Metastatic lesions uniformly showed low expression.</s><s>In these two <ref type="bibr" target="#b23">[23,</ref><ref type="bibr" target="#b24">24]</ref> and several other studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b26">26,</ref><ref type="bibr" target="#b27">27]</ref> expression in CC-RCC was uniformly several times higher than in normal tissue, papillary and chromophobe RCC with expression in papillary subtype significantly higher than in chromophobe RCC.</s><s>Overall rate of overexpression of adipophilin in CC-RCC cells was in a wide range from 64% up to 100% <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b24">24,</ref><ref type="bibr" target="#b30">30]</ref>.</s><s>Therefore it could be stated, that expression estimation at the mRNA level <ref type="bibr" target="#b24">[24]</ref> and protein level (our data) are well concordant.</s><s>Adipophilin was also a promising diagnostic marker of RCC in urine (for both CC-RCC and papillary RCC; no effect for chromophobe RCC, bladder cancer, prostate cancer, benign oncocytomas, angiomyolipomas) <ref type="bibr" target="#b25">[25]</ref>.</s></p><p><s>However, using mRNA-based techniques for biomarker detection in routine practice is challenging due to degradation issues.</s><s>Our study represents the first extensive evaluation of the adipophilin expression in renal cell carcinoma at the protein level with regard to its prognostic significance.</s><s>Importantly, only membrane    positivity in our study was correlated with clinical parameters (tumor stage, grade, pN-status) and showed a prognostic value for overall survival in Kaplan-Meyer and univariate Cox-regression analysis.</s><s>Localization of adipophilin at the cell membrane is not fully clear from the molecular biological point of view, although some studies provide the explanation for this phenomenon in terms of lipid droplet formation machinery in the cell membrane in certain circumstances and of the role of adipophilin in active transport through cell membrane.</s><s>Some other  <ref type="bibr" target="#b24">[24]</ref> demonstrated a multivariate prognostic significance of adipophilin on transcript level, which we could confirm in a validation analysis using publicly available mRNA expression data from The Cancer Genome Atlas.</s><s>However, in our attempt to validate this further on protein level, we failed, as membranous adipophilin lost its significance on multivariate analysis.</s></p><p><s>The functional role of adipophilin in tumor cells is yet unclear.</s><s>Overexpression of PLIN2 was shown to lead to lipid overload <ref type="bibr" target="#b32">[32,</ref><ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b34">34]</ref>.</s><s>In RCCs specifically, PLIN2 overexpression may be induced by VHL mutations <ref type="bibr" target="#b23">[23]</ref>.</s><s>The induction of the PLIN2 expression is also possible through the hypoxia <ref type="bibr" target="#b36">[35]</ref><ref type="bibr" target="#b37">[36]</ref><ref type="bibr" target="#b38">[37]</ref>, which is a cornerstone of VHL pathway alterations in CC-RCC <ref type="bibr" target="#b39">[38]</ref>.</s><s>This could explain the lipid overload in this type of tumor.</s><s>The presence of VHL mutation in tumor cells has been shown to carry a survival benefit for patients with CC-RCC, which could explain the less aggressive nature of the tumors with overexpressed adipophilin ( <ref type="bibr" target="#b23">[23,</ref><ref type="bibr" target="#b24">24]</ref> and our study).</s><s>Two further interesting studies <ref type="bibr" target="#b40">[39,</ref><ref type="bibr" target="#b41">40]</ref> point at cytoprotective overexpression of PLIN2 as the defense mechanism of the cell to lipid overload, which would otherwise lead to the apoptosis due to lipid toxicity given the improper storage of lipids in the cytoplasm <ref type="bibr" target="#b41">[40]</ref>.</s><s>There is also data showing that accumulation of the lipid droplets could have a malignancy promoting effect in tumors (See Supplementary Discussion 3) <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b42">41]</ref>.</s><s>This seems not to be a proper explanation of adipophilin overexpression in RCC.</s></p><p><s>One other interesting finding in our study is the differences in adipophilin expression in CC-RCC cases between male and female patients.</s><s>Given the fact, that higher expression supposes less aggressiveness and taking Comments: a -less than 10 cases into account the overall male to female ratio in RCC with approximately 2-3:1 <ref type="bibr" target="#b0">[1]</ref>, one could speculate, that in women tumor biology could be different.</s><s>Earlier such correlations were never showed for adipophilin expression in RCC and other tumor types <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b24">24]</ref>, although only one study <ref type="bibr" target="#b24">[24]</ref> embraced enough cases to reveal any associations with sex in RCC.</s><s>Increased expression of PLIN2 in women was earlier showed in skeletal muscle in one study <ref type="bibr" target="#b43">[42]</ref>, underpinning some physiological differences in lipid metabolism of different sexes.</s></p><p><s>One of the potential limitations of our study could be the undersampling issue.</s><s>It is well known that some tumors (including renal cell carcinoma) show substantial intratumoral heterogeneity, the extent of which is still understudied <ref type="bibr">[43]</ref>.</s><s>We have analyzed two tumor samples per patient and noticed significant differences of adipophilin expression only in a single patient of our cohort, which endorses the assumption of a relatively homogenous expression of adipophillin in renal cancer.</s></p><p><s>Drawing a conclusion, adipophilin seems to play an important role in metabolism of RCC and, probably, of many other tumor types (especially with clear-cell phenotype).</s><s>Even though we could not find a multivariate prognostic value in our data set, which could be also related to some limitations (particularly the number of patients), the prognostic role of adipophilin expression in CC-RCC is robustly corroborated by the analysis of TCGA.</s><s>Further studies on adipophilin expression are warranted with the use of different antibodies and correlations between mRNA expression and immunohistochemistry.</s></p><p><s>This study demonstrated, that adipophilin expression is correlated with many important clinical parameters in patients with clear cell RCC and has a univariate prognostic value in two independent cohorts of CC-RCC.</s><s>Further studies are needed to clarify if the multivariate prognostic value observed on the transcript level can be verified on the protein level with protocol modifications.</s><s>Also, the relationship of adipophilin expression and metabolic alterations in tumor cells warrants additional investigations, preferably using integrative methodologies (parallel mRNA and protein levels).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient selection</head><p><s>We have included 275 patients, who were operated on in the urological department of Charité Hospital (Berlin, Germany) due to renal cancer between 1993 and 2004.</s><s>Final pathology confirmed that all patients had a RCC of different histological subtypes.</s><s>Cases were selected according to tissue availability, without using any further selection criteria.</s><s>Patients with accompanying secondary malignancies were initially excluded.</s><s>All patients were prospectively followed-up.</s><s>The clinical characteristics of the patient cohort are presented in the Table <ref type="table" target="#tab_0">1</ref>.</s><s>For this cohort we had the data available on overall survival with median follow-up exceeding 7,5 years.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials</head><p><s>For our study we have used the formalin-fixed paraffin embedded archive tissue.</s><s>Initially tumor and normal tissues were fixed in the neutral buffered 10% formalin according to the institutional standards.</s><s>For all 275 patients tumor and normal tissue were representatively available.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Construction of tissue microarray (TMA)</head><p><s>A tissue microarray was constructed as described in <ref type="bibr" target="#b28">[28]</ref>.</s><s>Briefly, for every patient two cores of tumor and adjacent normal tissue were taken, each 1 mm in diameter, which were compiled in five paraffin blocks.</s><s>Histological control of the tissue content was carried out by an experienced uropathologist.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry protocol</head><p><s>The tissue microarray was cut (3 μm) and mounted on superfrost slides (Menzel Gläser, Brunswick, Germany).</s><s>After deparaffinization with xylene and gradual rehydration, antigen retrieval was achieved by pressure cooking in 0.01 mol/L citrate buffer for 5 min.</s><s>Slides were incubated with primary antibody (rabbit polyclonal adipophilin antibody; Cell Marque (Rocklin, California, USA); 393-A16; dilution 1:25).</s><s>The slides were counterstained with hematoxylin and aqueously mounted.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry evaluation</head><p><s>The immunohistochemic staining was evaluated by two experienced pathologists, blinded for clinical outcome.</s><s>The staining intensity was evaluated using a 4-tier grading system (0: negative; 1: weakly positive; 2: moderately positive; 3: strongly positive) for membrane and cytoplasm separately.</s><s>For further statistical analysis the moderately and strong adipophilin positive tumors (Staining grades 2 and 3) were grouped against the weakly stained and negative ones (Staining grades 0 and 1).</s><s>Statistical analysis was performed for membrane and cytoplasm stainings separately and also using a pooled analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethical issues</head><p><s>Permission of the institutional ethical committee (Charité, Berlin, Germany) was received for this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of the TCGA data</head><p><s>The extraction of the TCGA data (clinical data, mRNA expression data) was carried out for clear-cell subtype of the RCC (data version 28.01.2016).</s><s>These data were available for 533 patients with expression data generated using the Illumina HiSeq 2000 RNA Sequencing platform (Version 2).</s><s>Normalized results of the mRNA expression were used for analysis.</s><s>Overall survival was used as the end-point.</s><s>mRNA expression for PLIN2 was extracted for every patient / tumor, as well as for normal kidney tissue, available for 73 patients.</s><s>Some modifications of the database were performed before the analysis: exclusion of the patients with internally (by TCGA committee) revealed discrepancies in the clinical information, exclusion of the patients with follow-up &lt; 30 days and with incomplete clinical information.</s><s>Given these modifications 489 patient cases were available for analysis with 158 events (death) during follow-up in this group.</s><s>Two types of multivariate analyses were carried out with regard to tumor grade (1.</s><s>All patients; 2. The patients with tumor grades G2, G3 and G4), while there are only few patients (n=8) with G1 tumors in the modified TCGA cohort, which uniformly demonstrate excellent survival statistics, which distorts the Cox statistics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis was done using SPSS, version 22.0 (IBM Corporation, Armonk, New York, U.S.) and R (version 3.2.2).</s><s>Kaplan-Meyer curves, log rank test, univariate and multivariate Cox proportional hazards regression analysis were used for analysis of prognostic significance of adipophilin with regard to other clinical prognostic parameters.</s><s>Extraction of the TCGA mRNA expression data was done in R using TCGABiolinks package.</s><s>The best cut-off for the mRNA expression on the TCGA data was selected in R using the survMisc package (Cox-based selection).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: Staining patterns of the adipophilin in renal cell carcinoma (RCC).</s><s>(A) Vesicular (drop-like) staining of cytoplasm.</s><s>(B) Vesicular and granular staining of cytoplasm.</s><s>(C) Weak membrane staining.</s><s>(D) Strong membrane staining and vesicular and granular staining of cytoplasm.</s><s>(E) No staining of tumor cells in papillary RCC, granular staining of cytoplasm of macrophages (foamy cells), could be mistaken as tumor cells.</s><s>(F) No staining in chromophobe RCC.</s></p></div></figDesc><graphic coords="4,60.80,403.52,491.40,263.91" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: Membrane staining patterns of adipophilin in clear cell RCC with regard to: (A) pT-stage (p=0.001),</s><s>(B) pN-stage (p=0.096, in pN1 number of cases &lt; 10), (C) WHO/ISUP Tumor grade (p&lt;0.0001), and (D) Sex of the patient (p&lt;0.00001).</s></p></div></figDesc><graphic coords="5,80.30,50.00,452.40,275.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 :</head><label>3</label><figDesc><div><p><s>Figure 3: Kaplan-Meyer curves for overall survival of patients with clear cell RCC after tumor excision, stratified based on the adipophilin immunostaining (p-level using long-rank): (A) membrane staining (4-tier), p=0.014, (B) membrane staining (positive/negative), p=0.368, (C) membrane staining high (moderate and strong) vs low (negative and weak), p=0.006, (D) cytoplasm staining, 3-tier (negative, weak or moderate; there were no cases with strong cytoplasm staining), p=0.721.</s></p></div></figDesc><graphic coords="5,71.18,389.93,470.65,273.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 :</head><label>4</label><figDesc><div><p><s>Figure 4: Kaplan-Meyer curves for overall survival of patients with clear cell RCC from the TCGA-cohort (n=489) after tumor excision, stratified according the mRNA expression of the PLIN2 gene (adipophilin) with the expression cut-off = 17995 transcript calls.</s></p></div></figDesc><graphic coords="8,117.50,316.03,378.00,361.80" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 : Clinical characteristics of patient cohort with RCC (n=275)</head><label>1</label><figDesc></figDesc><table><row><cell>Parameter</cell><cell>Absolute</cell><cell>Proportion</cell></row><row><cell>Age, years mean (range)</cell><cell>61.0 (30-86)</cell><cell>-</cell></row><row><cell>Follow-up, months median (range)</cell><cell>91.0 (1-159)</cell><cell>-</cell></row><row><cell>Status to the end of follow-up</cell><cell></cell><cell></cell></row><row><cell>alive</cell><cell>192</cell><cell>69.8%</cell></row><row><cell>dead</cell><cell>83</cell><cell>30.2%</cell></row><row><cell>Sex:</cell><cell></cell><cell></cell></row><row><cell>male</cell><cell>187</cell><cell>68.0%</cell></row><row><cell>female</cell><cell>88</cell><cell>32.0%</cell></row><row><cell>Histological subtype:</cell><cell></cell><cell></cell></row><row><cell>clear cell</cell><cell>230</cell><cell>83.6%</cell></row><row><cell>papillary</cell><cell>35</cell><cell>12.7%</cell></row><row><cell>chromophobe</cell><cell>10</cell><cell>3.7%</cell></row><row><cell>pT-Stage (TNM 2002):</cell><cell></cell><cell></cell></row><row><cell>pT1a</cell><cell>100</cell><cell>36.4%</cell></row><row><cell>pT1b</cell><cell>66</cell><cell>24.0%</cell></row><row><cell>pT2</cell><cell>21</cell><cell>7.6%</cell></row><row><cell>pT3a</cell><cell>32</cell><cell>11.6%</cell></row><row><cell>pT3b</cell><cell>50</cell><cell>18.2%</cell></row><row><cell>pT3c</cell><cell>4</cell><cell>1.5%</cell></row><row><cell>pT4</cell><cell>2</cell><cell>0.7%</cell></row><row><cell>WHO/ISUP grade:</cell><cell></cell><cell></cell></row><row><cell>1</cell><cell>48</cell><cell>17.5%</cell></row><row><cell>2</cell><cell>154</cell><cell>56.0%</cell></row><row><cell>3</cell><cell>47</cell><cell>17.1%</cell></row><row><cell>4</cell><cell>16</cell><cell>5.8%</cell></row><row><cell>N/A a</cell><cell>10</cell><cell>3.6%</cell></row><row><cell>pN-Stage:</cell><cell></cell><cell></cell></row><row><cell>N0</cell><cell>146</cell><cell>53.1%</cell></row><row><cell>N+</cell><cell>16</cell><cell>5.8%</cell></row><row><cell>Nx</cell><cell>113</cell><cell>41.1%</cell></row><row><cell>Lymphadenectomy</cell><cell></cell><cell></cell></row><row><cell>Yes</cell><cell>150</cell><cell>54.4%</cell></row><row><cell>No</cell><cell>125</cell><cell>45.6%</cell></row><row><cell>M-Stage (clinical)</cell><cell></cell><cell></cell></row><row><cell>M0</cell><cell>245</cell><cell>89.1%</cell></row><row><cell>M1 synchronic</cell><cell>19</cell><cell>6.9%</cell></row><row><cell>M1 asynchronic</cell><cell>11</cell><cell>4.0%</cell></row><row><cell>R-status</cell><cell></cell><cell></cell></row><row><cell>R0</cell><cell>250</cell><cell>90.9%</cell></row><row><cell>R1</cell><cell>10</cell><cell>3.6%</cell></row><row><cell>R2</cell><cell>4</cell><cell>1.5%</cell></row><row><cell>not available</cell><cell>11</cell><cell>4.0%</cell></row><row><cell>Adrenalectomy</cell><cell></cell><cell></cell></row><row><cell>Yes</cell><cell>174</cell><cell>63.3%</cell></row><row><cell>No</cell><cell>101</cell><cell>36.7%</cell></row><row><cell>ECOG performance status</cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>189</cell><cell>68.8%</cell></row><row><cell>1</cell><cell>79</cell><cell>28.7%</cell></row><row><cell>2</cell><cell>7</cell><cell>2.5%</cell></row></table><note><p><s>Comments: a -No grading for chromophobe subtype</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 : Results of immunostaining using adipophilin antibodies in all subtypes of renal cell carcinoma (n=275)</head><label>2</label><figDesc></figDesc><table><row><cell>Staining</cell><cell></cell><cell cols="2">Membrane a frequency percentage</cell><cell>frequency</cell><cell>Cytoplasm b</cell><cell>percentage</cell></row><row><cell>0</cell><cell>Negative</cell><cell>155</cell><cell>56.3%</cell><cell>207</cell><cell></cell><cell>75.3%</cell></row><row><cell>1</cell><cell>Weak</cell><cell>45</cell><cell>16.4%</cell><cell>56</cell><cell></cell><cell>20.3%</cell></row><row><cell>2</cell><cell>Moderate</cell><cell>69</cell><cell>25.1%</cell><cell>12</cell><cell></cell><cell>4.4%</cell></row><row><cell>3</cell><cell>Strong</cell><cell>6</cell><cell>2.2%</cell><cell>0</cell><cell></cell><cell>0.0%</cell></row><row><cell cols="7">Comments: a all positive cases are clear cell subtype, except 2 case of papillary subtype (1x weak and 1x moderate</cell></row><row><cell cols="7">staining), b all positive cases are clear cell subtype, with except of 3 other cases with papillary subtype (3x weak)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 : Univariate analysis of prognostic significance of different factors for overall survival in patients with clear cell renal cell carcinoma, n=230 (Cox regression)</head><label>3</label><figDesc></figDesc><table><row><cell>N</cell><cell>Parameter</cell><cell>HR</cell><cell>95% Confidence interval</cell><cell>Significance</cell></row><row><cell>1</cell><cell>pT-stage</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pT1</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>pT2</cell><cell>2.68</cell><cell>1.01-7.12</cell><cell>0.048</cell></row><row><cell></cell><cell>pT3a</cell><cell>3.61</cell><cell>1.74-7.49</cell><cell>0.001</cell></row><row><cell></cell><cell>pT3b-pT4</cell><cell>7.05</cell><cell>4.05-12.29</cell><cell>&lt;0.0001</cell></row><row><cell>2</cell><cell>pN-stage: pN1 vs pN0/ pNx</cell><cell>6.1</cell><cell>2.97-12.53</cell><cell>&lt;0.0001</cell></row><row><cell>3</cell><cell>R-status, pos. vs neg.</cell><cell>9.41</cell><cell>4.56-19.44</cell><cell>&lt;0.0001</cell></row><row><cell>4</cell><cell>WHO/ISUP grade</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>2</cell><cell>3.0</cell><cell>1.18-7.64</cell><cell>0.021</cell></row><row><cell></cell><cell>3</cell><cell>4.22</cell><cell>1.52-11.73</cell><cell>0.006</cell></row><row><cell></cell><cell>4</cell><cell>16.07</cell><cell>5.62-45.9</cell><cell>&lt;0.0001</cell></row><row><cell>5</cell><cell>Age, continuous</cell><cell>1.02</cell><cell>1.00-1.05</cell><cell>0.123</cell></row><row><cell>6</cell><cell>Sex, female vs male</cell><cell>0.87</cell><cell>0.52-1.43</cell><cell>0.572</cell></row><row><cell>7</cell><cell>ECOG status</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>1</cell><cell>3.53</cell><cell>2.16-5.77</cell><cell>&lt;0.0001</cell></row><row><cell></cell><cell>2 a</cell><cell>17.76</cell><cell>6.66-47.32</cell><cell>&lt;0.0001</cell></row><row><cell>8</cell><cell>Membrane, 4-tier</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>1</cell><cell>1.18</cell><cell>0.67-2.08</cell><cell>0.572</cell></row><row><cell></cell><cell>2</cell><cell>0.4</cell><cell>0.21-0.76</cell><cell>0.005</cell></row><row><cell></cell><cell>3</cell><cell>&lt;0.001</cell><cell>-b</cell><cell>0.963</cell></row><row><cell>9</cell><cell>Membrane, low vs high</cell><cell>2.90</cell><cell>1.55-5.42</cell><cell>0.001</cell></row><row><cell>10</cell><cell>Membrane, positive vs negative</cell><cell>0.66</cell><cell>0.41-1.06</cell><cell>0.085</cell></row><row><cell>11</cell><cell>Cytoplasm, 3-tier</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>1</cell><cell>0.69</cell><cell>0.37-1.29</cell><cell>0.691</cell></row><row><cell></cell><cell>2</cell><cell>0.57</cell><cell>0.13-2.12</cell><cell>0.359</cell></row><row><cell cols="4">Comments: a -&lt; 10 patients, b -{&lt;0.0001 -1.23E+231}, 6 outlier cases in analysis</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 : Multivariate analysis of prognostic significance of selected factors for overall survival in patients with clear cell renal cell carcinoma, n=230 (Cox regression)</head><label>4</label><figDesc></figDesc><table><row><cell>N</cell><cell>Parameter</cell><cell>HR</cell><cell>95% Confidence interval</cell><cell>Significance</cell></row><row><cell>1</cell><cell>pT-stage</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pT1</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>pT2</cell><cell>1.34</cell><cell>0.44-4.06</cell><cell>0.603</cell></row><row><cell></cell><cell>pT3a</cell><cell>2.40</cell><cell>1.08-5.33</cell><cell>0.032</cell></row><row><cell></cell><cell>pT3b-pT4</cell><cell>4.27</cell><cell>2.27-8.05</cell><cell>&lt;0.0001</cell></row><row><cell>2</cell><cell>pN-stage</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pN0/pNx</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>pN1*</cell><cell>0.74</cell><cell>0.28-1.91</cell><cell>0.531</cell></row><row><cell>3</cell><cell>R-status</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>R0</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>R+</cell><cell>1.77</cell><cell>0.66-4.78</cell><cell>0.259</cell></row><row><cell>4</cell><cell>WHO/ISUP grade</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>2</cell><cell>2.59</cell><cell>1.00-6.72</cell><cell>0.051</cell></row><row><cell></cell><cell>3</cell><cell>2.15</cell><cell>0.73-6.36</cell><cell>0.166</cell></row><row><cell></cell><cell>4</cell><cell>7.53</cell><cell>2.44-23.25</cell><cell>&lt;0.0001</cell></row><row><cell>5</cell><cell>ECOG status</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>1</cell><cell>2.38</cell><cell>1.35-4.21</cell><cell>0.003</cell></row><row><cell></cell><cell>2 a</cell><cell>5.78</cell><cell>1.38-24.17</cell><cell>0.016</cell></row><row><cell>6</cell><cell>Membrane staining</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>high</cell><cell>1</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>low</cell><cell>1.52</cell><cell>0.76-3.02</cell><cell>0.235</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.impactjournals.com/oncotarget</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>CC-RCC, clear cell renal cell carcinoma; HR, hazard ratio; ISUP, Internation Society of Urological Pathology; RCC, renal cell carcinoma; TCGA, The Cancer Genome Atlas; WHO, World Health Organization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head><p><s>Study design: GK, KJ, CS Data acquisition: YT, CL, KJ, CS, GK Data analysis: YT, GK, SM Manuscript writing: YT, GK</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICTS OF INTEREST</head><p><s>All authors report no conflicts of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FUNDING</head><p><s>No external funding was received for this work.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The epidemiology of renal cell carcinoma</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ljungberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jacqmin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weikert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="615" to="621" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ackerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Simon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Cell Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="472" to="478" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Metabolic pathways promoting cancer cell survival and growth</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Boroughs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Deberardinis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Cell Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="351" to="359" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Adipophilin/perilipin-2 as a lipid dropletspecific marker for metabolically active cells and diseases associated with metabolic dysregulation</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Straub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gyoengyoesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hashani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Pawella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Herpel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macher-Goeppinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schirmacher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="617" to="631" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Isolation and characterization of a fulllength cDNA coding for an adipose differentiation-related protein</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Serrero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="7856" to="7860" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yang</forename><surname>Sy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Exp Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1190" to="1196" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Osako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Horii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Iwase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Akiyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="509" to="519" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Intracytoplasmic lipid accumulation in apocrine carcinoma of the breast evaluated with adipophilin immunoreactivity: a possible link between apocrine carcinoma and lipid-rich carcinoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Moritani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ichihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oiwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shiraiwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="861" to="867" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pucer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Brglez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Payré</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pungerčar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lambeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Petan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">111</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mentrikoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Wendroth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Wick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Appl Immunohistochem Mol Morphol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="635" to="641" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Lipid dropletassociated PAT-proteins show frequent and differential expression in neoplastic steatogenesis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Straub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Herpel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zimbelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Breuhahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macher-Goeppinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Warth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lehmann-Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Longerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schirmacher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="480" to="492" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">V</forename><surname>Mariano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Azañero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">W</forename><surname>Da Cunha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Coutinho-Camilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">P</forename><surname>De Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Kowalski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Altemani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="558" to="567" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Ghadimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Demicco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Creighton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lusby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hornick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ravi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Lazar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1868" to="1877" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Ambrosio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Piccaluga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ponzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Rocca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Malagnino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Onorati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Falco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Calbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ogwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Pileri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Doglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leoncini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e44315</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Grippo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Fitchev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bentrem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Melstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dangi-Garimella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Krantz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Heiferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Adrian</forename><forename type="middle">K</forename><surname>Cornwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Flesche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Talamonti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1454" to="1464" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Immunohistochemical staining for adipophilin, perilipin and TIP47</title>
		<author>
			<persName><forename type="first">K</forename><surname>Muthusamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Halbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1166" to="1170" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Intracytoplasmic adipophilin immunopositivity: a pitfall in the distinction of metastatic renal carcinoma from sebaceous carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rangel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Mccalmont</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1193" to="1195" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mulay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Honavar</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>including androgen receptor</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Can J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="326" to="332" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">PCR-array gene expression profiling of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kurokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Matoba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakamori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Takemasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Umeshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Monden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Oncocytic adrenal cortical tumor with cytoplasmic inclusions and hyaline globules</title>
		<author>
			<persName><forename type="first">T</forename><surname>Al-Zaid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Alroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pfannl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Strissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Layer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Carpinito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Tischler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virchows Arch</title>
		<imprint>
			<biblScope unit="volume">453</biblScope>
			<biblScope unit="page" from="301" to="306" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Expression of adipophilin in gastric epithelial neoplasia is www.impactjournals.com/oncotarget associated with intestinal differentiation and discriminates between adenoma and adenocarcinoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gushima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kurisaki-Arakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukumura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virchows Arch</title>
		<imprint>
			<biblScope unit="volume">468</biblScope>
			<biblScope unit="page" from="169" to="177" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray</title>
		<author>
			<persName><forename type="first">J</forename><surname>Matsubara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sekine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sakuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakamori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Okusaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="2195" to="2203" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tabuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nagashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nakaigawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishiguro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Inayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hattori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamada-Okabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kubota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="377" to="387" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shioi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hattori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nakaigawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nagashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kubota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="152" to="160" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Morrissey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Mellnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Figenshau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bhayani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Kharasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="204" to="212" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Gene signatures of progression and metastasis in renal cell cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Otu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Spentzos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kolia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Beecken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fellbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Pantuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonas</forename><forename type="middle">D</forename><surname>Libermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="5730" to="5739" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Yusenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Kuiper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boethe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ljungberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Van Kessel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kovacs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">152</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Fritzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oelrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Johannsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kristiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Moch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kristiansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="7035" to="7042" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Varela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caron</forename><forename type="middle">E</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Dhir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dhir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ahima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Genomics</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1125" to="1131" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Dannenmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hermanns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bransi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Matter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Boehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stevanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schraml</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Knuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Den Broek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Immunol Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="288" to="295" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Direct interaction of Plin2 with lipids on the surface of lipid droplets: a live cell FRET analysis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mcintosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Senthivinayagam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Lwande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Storey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Atshaves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="C728" to="742" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Serrero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="16825" to="16830" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Listenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Ostermeyer-Fay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="2751" to="2761" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Hypoxia-induced alterations of lipid metabolism in the normal human hepatic L02 cell line</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Zhonghua Gan Zang Bing Za Zhi</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="30" to="34" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Oxygeninduced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Boros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Torday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paul</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Rehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Genet Metab</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="230" to="236" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Saarikoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hankinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">530</biblScope>
			<biblScope unit="page" from="186" to="190" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Czyzyk-Krzeska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Conaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Conaway</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="10430" to="10435" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sztalryd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Kimmel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="96" to="101" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Lipid droplet-associated proteins protect renal tubular cells from fatty acid-induced apoptosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Urahama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohsaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maruyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuzawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="1286" to="1294" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density</title>
		<author>
			<persName><forename type="first">W</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Fitchev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Cornwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Crawford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Savkovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="16274" to="16281" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Perilipin family (PLIN) proteins in human skeletal muscle: the effect of sex, obesity, and endurance training</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Samjoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Devries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Stevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Robertshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Tarnopolsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Appl Physiol Nutr Metab</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="724" to="735" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gerlinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Horswell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Larkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Rowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Salm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Varela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mcgranahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Phillimore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Begum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="225" to="233" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
